We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Web Portal Offers Fast Search of Trial Data

By HospiMedica staff writers
Posted on 27 Mar 2006
A new website has been launched that is designed to increase the transparency of industry-sponsored clinical trials of new medicines by providing a faster and more-precise search, available in five languages.

The portal was developed by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA, Geneva, Switzerland) in cooperation with IBM Corp. More...
(White Plains, NY, USA). This is the first Internet search engine constructed to link to online information about ongoing and completed clinical trials sponsored by researched-based pharmaceutical companies worldwide. Users can search for clinical trial information in German, French, Japanese, and Spanish, as well as English. Depending on the pattern of use, additional languages may be added later.

"Furthermore,” announced Dr. Harvey E. Bale, director general of the IFPMA, "since many people are unfamiliar with medical expressions, we have improved the search facility so that it suggests synonyms for medical conditions and helps to correct misspelled words, including the names of medicines.” The extended reach now allows a search for trials corresponding both to the term entered by a layperson and the term's synonyms. According to Dr. Bale, multiple criteria searches are now easier as are searches by geographical area. "In this way, anyone can program the search engine to look for trials which are underway in the area where you live, in the disease that interests you.”

The amount of clinical trial information accessible via the IFPMA portal has increased from 26,000 pages to more than 88,000 pages, and this number continues to climb. The number of linking sites has also increased, from 10 to 15. These linking sites include pharmaceutical company sites, pharmaceutical industry association resources, and U.S. governmental sites, such as the U.S. Library of Medicine. Other resources, such as the European Union's planned Europharm facility, will be linked as soon as they become available.

The IFPMA is a global nonprofit non-governmental organization representing research-based pharmaceutical, biotechnology, and vaccine companies and national industry associations in developed and developing countries.



Related Links:
IFPMA

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.